133 related articles for article (PubMed ID: 12495121)
1. Delays in diagnosing breast cancer--the impact of concurrent pregnancy and lactation.
Saunders C; Ives A; Puckridge P; Semmens J
Aust N Z J Obstet Gynaecol; 2002 Nov; 42(5):573-5. PubMed ID: 12495121
[No Abstract] [Full Text] [Related]
2. [Pregnancy and breast cancer].
Ramírez-Torres N; Asbun-Bojalil J; Hernández-Valencia M
Cir Cir; 2013; 81(2):98-107. PubMed ID: 23522309
[TBL] [Abstract][Full Text] [Related]
3. Successful pregnancy outcome with 5-flurouracil, epirubicin, cyclophosphamide chemotherapy, and hemostatic radiotherapy with abdominal shielding for metastatic invasive intraductal breast carcinoma.
Sharma JB; Pushparaj M; Kumar S; Roy KK; Raina V; Malhotra N
Arch Gynecol Obstet; 2009 Mar; 279(3):415-7. PubMed ID: 18642013
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy for early breast cancer.
Costa SD; Bischoff J
N Engl J Med; 2007 Mar; 356(12):1268-9. PubMed ID: 17377168
[No Abstract] [Full Text] [Related]
5. Pregnancy associated breast cancer: a case report.
Ginopoulos PV; Michail GD; Kourounis GS
Eur J Gynaecol Oncol; 2004; 25(2):261-3. PubMed ID: 15032300
[TBL] [Abstract][Full Text] [Related]
6. Salvage treatments in relapsing resectable breast cancer.
Valagussa P; Brambilla C; Zambetti M; Bonadonna G
Recent Results Cancer Res; 1989; 115():69-76. PubMed ID: 2696043
[No Abstract] [Full Text] [Related]
7. [Diagnosis and treatment of pregnancy-associated breast cancer].
Dashian GA; Semiglazov VF; Semiglazov VV; Topuzov ÉÉ; Krivorot'ko PV; Donskikh RV; Tabagua TT; Grechukhina IA; Dzhukaeva TsS
Vopr Onkol; 2011; 57(5):584-91. PubMed ID: 22238927
[No Abstract] [Full Text] [Related]
8. Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer.
Andreadis C; Charalampidou M; Diamantopoulos N; Chouchos N; Mouratidou D
Gynecol Oncol; 2004 Oct; 95(1):252-5. PubMed ID: 15385141
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics and prognostic factors of postoperative chemotherapy for female breast cancer patients under 30 years of age: a report of 129 patients].
Wang ZH; Xu BH
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):111-3. PubMed ID: 15946553
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of epirubicin and cyclophosphamide in 2-dose levels and classical CMF protocol in node-positive breast cancer. An adjuvant Phase III trial].
Ost E; Illiger HJ
Strahlenther Onkol; 2002 Jan; 178(1):54-5. PubMed ID: 11977396
[No Abstract] [Full Text] [Related]
11. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
Boccardo F; Rubagotti A; Bruzzi P; Cappellini M; Isola G; Nenci I; Piffanelli A; Scanni A; Sismondi P; Santi L
J Clin Oncol; 1990 Aug; 8(8):1310-20. PubMed ID: 2199618
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options.
Gentilini O; Masullo M; Rotmensz N; Peccatori F; Mazzarol G; Smeets A; Simsek S; De Dosso S; Veronesi P; Intra M; Zurrida S; Viale G; Goldhirsch A; Veronesi U
Eur J Surg Oncol; 2005 Apr; 31(3):232-6. PubMed ID: 15780556
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer during pregnancy.
Gwyn KM; Theriault RL
Curr Treat Options Oncol; 2000 Aug; 1(3):239-43. PubMed ID: 12057166
[TBL] [Abstract][Full Text] [Related]
14. The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer.
Sørensen B; Bastholt L; Mirza MR; Gjedde SB; Jakobsen P; Mouridsen HT; Rose C
Cancer Chemother Pharmacol; 1994; 34(5):439-43. PubMed ID: 8070013
[TBL] [Abstract][Full Text] [Related]
15. A case of advanced male breast cancer successfully treated by 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy combined with tamoxifen.
Tanaka Y; Ohmori Y; Toki T; Okazaki Y; Ogoshi S; Ogawa Y
Nihon Geka Hokan; 1995 Jan; 64(1):15-22. PubMed ID: 8534185
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group.
Coombes RC; Bliss JM; Wils J; Morvan F; Espié M; Amadori D; Gambrosier P; Richards M; Aapro M; Villar-Grimalt A; McArdle C; Pérez-López FR; Vassilopoulos P; Ferreira EP; Chilvers CE; Coombes G; Woods EM; Marty M
J Clin Oncol; 1996 Jan; 14(1):35-45. PubMed ID: 8558217
[TBL] [Abstract][Full Text] [Related]
17. [Breast carcinoma and pregnancy. A case report].
Serrano Migallón JA; Sandoval Guerrero F; Miranda Hernández H; de la Garza Navarro JM
Ginecol Obstet Mex; 1988 Oct; 56():281-4. PubMed ID: 2856450
[No Abstract] [Full Text] [Related]
18. [Therapy of metastatic breast cancer at the Ulm Tumor Center in 1980 and 1990].
Porzsolt F
Onkologie; 1990 Dec; 13(6):468-72. PubMed ID: 2092286
[No Abstract] [Full Text] [Related]
19. Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancer.
Boccardo F; Amadori D; Guglielmini P; Sismondi P; Farris A; Agostara B; Gambi A; Catalano G; Faedi M; Rubagotti A
Oncology; 2010; 78(3-4):274-81. PubMed ID: 20530973
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan.
Kimura M; Tominaga T; Takatsuka Y; Toi M; Abe R; Koyama H; Takashima S; Nomura Y; Miura S; Kimijima I; Tashiro H; Ohashi Y;
Breast Cancer; 2010 Jul; 17(3):190-8. PubMed ID: 19575284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
